BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 8525294)

  • 1. Over-expression of CDKIs p15INK4b, p16INK4a and p21CIP1/WAF1 genes mediate growth arrest in human osteosarcoma cell lines.
    Agiostratidou G; Derventzi A; Gonos ES
    In Vivo; 2001; 15(5):443-6. PubMed ID: 11695244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the transformed phenotype and induction of differentiation-like characteristics in cultured ovarian tumor cells by chronic treatment with progesterone.
    Blumenthal M; Kardosh A; Dubeau L; Borok Z; Schönthal AH
    Mol Carcinog; 2003 Dec; 38(4):160-9. PubMed ID: 14639655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of tumor progression by transcriptional profiling of mouse MK16 cell lines transformed with human papillomavirus type 16 E6 and E7 oncogenes and activated H-ras.
    Smahel M; Smahelová J; Tejklová P; Tachezy R; Jelínek F
    Oncol Rep; 2005 Dec; 14(6):1665-74. PubMed ID: 16273273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
    Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
    J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M; Xiong Y
    Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sox2 acts as a rheostat of epithelial to mesenchymal transition during neural crest development.
    Mandalos N; Rhinn M; Granchi Z; Karampelas I; Mitsiadis T; Economides AN; Dollé P; Remboutsika E
    Front Physiol; 2014; 5():345. PubMed ID: 25309446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of cyclin-dependent kinase inhibitors in monolayer and spheroid cultures of tumorigenic and nontumorigenic fibroblasts.
    LaRue KE; Bradbury EM; Freyer JP
    Cancer Res; 1998 Mar; 58(6):1305-14. PubMed ID: 9515820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase inhibitor expression in pulmonary Clara cells transformed with SV40 large T antigen in transgenic mice.
    Magdaleno SM; Wang G; Mireles VL; Ray MK; Finegold MJ; DeMayo FJ
    Cell Growth Differ; 1997 Feb; 8(2):145-55. PubMed ID: 9040936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin.
    Rodriguez-Puebla ML; LaCava M; Gimenez-Conti IB; Johnson DG; Conti CJ
    Oncogene; 1998 Oct; 17(17):2251-8. PubMed ID: 9811455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
    Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
    Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cell transformation].
    Monier R
    Rev Prat; 1995 Oct; 45(15):1867-72. PubMed ID: 8525294
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.